We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Artificial Joints Toughen Up with Gamma Radiation Boost

By HospiMedica International staff writers
Posted on 13 Oct 2011
A blast of gamma radiation may toughen up plastic prosthetic joints to make them strong enough to last for years, according to researchers in China.

The researchers published their findings in the September 2011 issue of the International Journal of Biomedical Engineering and Technology. Whole joint replacement, such as hip and knee replacement, typically use stainless steel, titanium alloys, or ceramics to replace the injured or diseased bone of the joint. More...
Nonstick polymer or nylon is commonly used to coat the artificial joint to simulate the cartilage. However, none of these materials are ideal as they generate debris within the body as the joint is used, which leads to inflammation, pain, and other problems.
Now, Dr. Maoquan Xue, from the Changzhou Institute of Light Industry Technology (China), has investigated the effect of adding ceramic particles and fibers to two experimental materials for coating prosthetic joints, UHMWPE (ultra-high-molecular-weight polyethylene) and PEEK (polyether ether ketone). Alone, neither UHMWPE nor PEEK is suitable as prosthetic cartilage materials because both crack and fracture with the sort of everyday stresses that a hip or knee joint would exert on them. The drawback is that the long polymer chains within the material can readily propagate applied forces causing tiny fractures to grow quickly and the material to fail.

Dr. Xue has now demonstrated that by adding ceramic particles to the polymers and then blasting the composite with a short burst of gamma-radiation it is possible to break the main polymer chains without disrupting the overall structure of the artificial cartilage. There is then no way for microscopic fractures to be propagated throughout the material because there are no long stretches of polymer to carry the force from one point to the next. The resulting treated material is thus much tougher than the polymer alone and will not produce the problematic debris within a joint that might otherwise lead to inflammation and pain for the patient.

Dr. Xue added that the treated composite materials might also be more biocompatible and so less likely to be rejected by the patient’s immune system on implantation. He suggests that the specific structure of the composites would also be receptive to addition of bone-generating cells, osteocytes or stem cells, which could help a prosthetic joint be integrated more naturally into the body.

Related Links:
Changzhou Institute of Light Industry Technology


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.